PowderJect is building diagnostic portfolio
This article was originally published in Clinica
Executive Summary
UK-based PowderJect Pharmaceuticals is attempting to widen its product base by developing a range of diagnostic products designed around its dry powder needleless injection system. The company says it plans to "capitalise on emerging trends in the diagnostics industry such as testing at home".